Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.18%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) Gross margin
Labcorp Holdings Inc.'s gross margin over the twelve months to 30 September 2026 was 29.0%, up 0.2 percentage points from fiscal 2025 (28.8%). Over the past ten years it has ranged from 27.7% (fiscal 2023) to 38.0% (fiscal 2021); the current reading is higher than 45% of that period. That is below the Diagnostics & Research industry median of 48.3% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 28.8% | 0.90 |
| FY2024 | 27.9% | 0.19 |
| FY2023 | 27.7% | (3.59) |
| FY2022 | 31.3% | (6.75) |
| FY2021 | 38.0% | 2.58 |
| FY2020 | 35.4% | 7.28 |
| FY2019 | 28.2% | 0.12 |
| FY2018 | 28.0% | (1.96) |
| FY2017 | 30.0% | 0.11 |
| FY2016 | 29.9% | (3.57) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 29.1% | (0.72) |
| Jun 2026 | 29.8% | 1.14 |
| Mar 2026 | 28.7% | 0.41 |
| Dec 2025 | 28.3% | (0.52) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| MEDP Medpace Holdings, Inc. compare | 72.2% |
| ILMN Illumina, Inc. compare | 67.9% |
| GH Guardant Health, Inc. compare | 65.2% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 49.5% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.1% |
| LH Labcorp Holdings Inc. | 29.0% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement